Prader-willi syndrome and sleep-disordered breathing

Pediatric Annals

Volumn 42, Issue 10, 2013, Pages 200-204

  Miller, Jennifer ^a   Wagner, Mary ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; MODAFINIL; OREXIN;

ACTIMETRY; APPETITE DISORDER; ARTICLE; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; ENDOCRINE DISEASE; HUMAN; HYPERCAPNIA; MUSCLE MASS; NARCOLEPSY; OBESITY; POLYSOMNOGRAPHY; PRADER WILLI SYNDROME; SLEEP DISORDERED BREATHING; SOMNOLENCE; UPPER RESPIRATORY TRACT INFECTION;

HUMAN GROWTH HORMONE; HUMANS; POLYSOMNOGRAPHY; PRADER-WILLI SYNDROME; SLEEP APNEA SYNDROMES;

EID: 84886037749     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20130924-10     Document Type: Article

References (34)

1. Cassidy SB, Driscoll DJ. Prader-Willi syndrome. Eur J Hum Genet. 2009;17(1):3-13.
2. Butler MG, Fischer W, Kibiryeva N, Bittel DC. Array comparative genomic hybridization (aCGH) analysis in Prader-Willi syndrome. Am J Med Genet A. 2008;146(7):854-860.
3. Bruni O, Verrillo E, Novelli L, Ferri R. Prader-Willi syndrome: sorting out the relationships between obesity, hypersomnia, and sleep apnea. Curr Opin Pulm Med. 2010;16(6):568-573.
4. Miller JL, Shuster J, Theriaque D, Driscoll DJ, Wagner M. Sleep disordered breathing in infants with Prader-Willi syndrome during the first 6 weeks of growth hormone therapy: a pilot study. J Clin Sleep Med. 2009;5(5):448-453.
5. de Lind van Wijngaarden RF, Joosten KF, van den Berg S, et al. The relationship between central adrenal insufficiency and sleep-related breathing disorders in children with Prader-Willi syndrome. J Clin Endocrinol Metab. 2009;94(7):2387-2393.
6. Verrillo E, Bruni O, Franco P, et al. Analysis of NREM sleep in children with Prader-Willi syndrome and the effect of growth hormone treatment. Sleep Med. 2009;10(6):646-650.
7. Williams K, Scheimann A, Sutton V, Hayslett E, Glaze DG. Sleepiness and sleep disordered breathing in Prader-Willi syndrome: relationship to genotype, growth hormone therapy, and body composition. J Clin Sleep Med. 2008;4(2):111-118.
8. Lin HY, Lin SP, Lin CC, et al. Polysomnographic characteristics in patients with Prader-Willi syndrome. Pediatr Pulmonol. 2007;42(10):881-887.
9. Al-Saleh S, Al-Naimi A, Hamilton J, et al. Longitudinal evaluation of sleep-disordered breathing in children with Prader-Willi Syndrome during 2 years of growth hormone therapy. J Pediatr. 2013;162(2):263-8.e1.
10. Vandeleur M, Davey MJ, Nixon GM. Are sleep studies helpful in children with Prader-Willi syndrome prior to commencement of growth hormone therapy? J Paediatr Child Health. 2013;49(3):238-241.
11. Maas AP, Sinnema M, Didden R, et al. Sleep disturbances and behavioural problems in adults with Prader-Willi syndrome. J Intellect Disabil Res. 2010;54(10):906-917.
12. Festen DA, Wevers M, de Weerd AW, et al. Psychomotor development in infants with Prader-Willi syndrome and associations with sleep-related breathing disorders. Pediatr Res. 2007;62(2):221-224.
13. Camfferman D, Lushington K, O'Donoghue F, Doug McEvoy R. Obstructive sleep apnea syndrome in Prader-Willi syndrome: an unrecognized and untreated cause of cognitive and behavioral deficits? Neuropsychol Rev. 2006;16(3):123-129.
14. Nevsimalova S, Vankova J, Stepanova I, et al. Hypocretin deficiency in Prader-Willi syndrome. Eur J Neurol. 2005;12(1):70-72.
15. Hilaire G, Voituron N, Menuet C, et al. The role of serotonin in respiratory function and dysfunction. Respir Physiol Neurobiol. 2010;174(1-2):76-88.
16. Urquhart DS, Gulliver T, Williams G, et al. Central sleep-disordered breathing and the effects of oxygen therapy in infants with Prader-Willi syndrome. Arch Dis Child. 2013;98(8):592-595.
17. Miller J, Silverstein J, Shuster J, Driscoll DJ, Wagner M. Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome. J Clin Endocrinol Metab. 2006;91(2):413-417.
18. Pelttari L, Polo O, Rauhala E, Vuoriluoto J, Aitasalo K, Hyyppä MT, Kronholm E, Irjala K, Viikari J. Nocturnal breathing abnormalities in acromegaly after adenomectomy. Clin Endocrinol (Oxf). 1995 Aug;43(2):175-82.
19. Pavone M, Paglietti MG, Petrone A, et al. Adenotonsillectomy for obstructive sleep apnea in children with Prader-Willi syndrome. Pediatr Pulmonol. 2006;41(1):74-79.
20. DeMarcantonio MA, Darrow DH, Gyuricsko E, Derkay CS. Obstructive sleep disorders in Prader-Willi syndrome: the role of surgery and growth hormone. Int J Pediatr Otorhinolaryngol. 2010;74(11):1270-1272.
21. Eiholzer U, Nordmann Y, L'Allemand D. Fatal outcome of sleep apnoea in PWS during the initial phase of growth hormone treatment. A case report. Horm Res. 2002;58(suppl 3):24-26.
22. Van Vliet G, Deal CL, Crock PA, Robitaille Y, Oligny LL. Sudden death in growth hormone-treated children with Prader-Willi syndrome. J Pediatr. 2004;144(1):129-131.
23. Stafler P, Wallis C. Prader-Willi syndrome: who can have growth hormone? Arch Dis Child. 2008;93(4):341-345.
24. Meinhardt U, Christiansen JS, Farholt S, et al. The efficacy and safety of long-term norditropin treatment in children with Prader-Willi syndrome. Horm Metab Res. 2013;45(7):532-536.
25. Whitman, Myers. 2013. Prader-Willi syndrome and growth hormone therapy: take a deep breath and weigh the data. J Pediatr. 2013 Feb;162(2):224-6.
26. Wolfgram PM, Carrel AL, Allen DB. Long-term effects of recombinant human growth hormone therapy in children with Prader-Willi syndrome. Curr Opin Pediatr. 2013;25(4):509-514.
27. Festen DA, de Weerd AW, van den Bossche RA, et al. Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment. J Clin Endocrinol Metab. 2006;91(12):4911-4915.
28. Nishino S, Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/ orexin system. Sleep Med Rev. 2005;9(4):269-310.
29. Ganjavi H, Shapiro CM. Hypocretin/orexin: a molecular link between sleep, energy regulation, and pleasure. J Neuropsychiatry Clin Neurosci. 2007;19(4):413-419.
30. Dauvilliers Y, Baumann CR, Carlander B, et al. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry. 2003;74(12):1667-1673.
31. Maas AP, Didden R, Bouts L, Smits MG, Curfs LM. Scatter plot analysis of excessive daytime sleepiness and severe disruptive behavior in adults with Prader-Willi syndrome: a pilot study. Res Dev Disabil. 2009;30(3):529-537.
32. De Cock VC, Diene G, Molinas C, et al. Efficacy of modafinil on excessive daytime sleepiness in Prader-Willi syndrome. Am J Med Genet A. 2011;155A(7):1552-1557.
33. Zandieh S, Ramgopal S, Khatwa U, et al. The maintenance of wakefulness test in pediatric narcolepsy. Pediatr Neurol. 2013;48(6):443-446.
34. Sullivan SS. Narcolepsy in adolescents. Adolesc Med State Art Rev. 2010;21(3):542-555.